Ma. Rea et al., MODULATION OF HUMAN EPIDERMAL-CELL RESPONSE TO 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN BY EPIDERMAL GROWTH-FACTOR, Carcinogenesis, 19(3), 1998, pp. 479-483
Cultured human epidermal cells were treated with 2,3,7,8-tetrachlorodi
benzo-p-dioxin (TCDD) in the presence or absence of epidermal growth f
actor (EGF). In both normal keratinocytes and a spontaneously immortal
ized keratinocyte (SIK) line, TCDD treatment in the absence of EGF ind
uced a marked reduction in colony size and cell number, and it perturb
ed colony morphology. These effects were largely prevented by EGF, ind
icating that growth factor action in the cellular microenvironment may
considerably modify TCDD action in target cells. Both TCDD and EGF su
bstantially reduced expression of the differentiation markers keratin
1 and keratin 10 in the normal and immortalized cells, and did so in a
n additive fashion. The cells did not display a general loss of differ
entiated function, since several other markers, including involucrin,
were little affected. EGF dramatically stimulated telomerase activity
in SIK cultures, and TCDD prevented this action but not by reducing ce
ll growth. However, EGF did not stimulate telomerase activity in norma
l human epidermal cells despite an evident increase in their growth. T
he growth factor stimulation of telomerase in the minimally deviated S
IK line suggests that derepression of enzyme activity in normal cells
may occur in a stepwise fashion during neoplastic progression. TCDD co
uld act as a late stage tumor promoter by selecting for variants in wh
ich telomerase is constitutively active.